Introduction {#s1}
============

Mammalian cells maintain elaborate ways to respond to amino acid availability and a prominent sensor is the protein kinase mammalian (or mechanistic) target of rapamycin complex 1 (mTORC1) ([@bib49]; [@bib29]). Under plentiful aa conditions mTORC1 is active and it in turn activates several different downstream targets leading to protein synthesis and cell growth. When amino acids are scarce, mTORC1 becomes inactive and this leads to a slow-down in protein synthesis and growth and an induction of autophagy, a pathway that generates nutrients from self-digestion of cellular material ([@bib19]; [@bib28]; [@bib10]; [@bib47]).

The mechanism by which amino acids are sensed by mTORC1 is beginning to be elucidated (reviewed in [@bib30]; [@bib23]; [@bib4]). It appears that the active form of mTORC1 that responds positively to amino acid availability resides on late endosomal/lysosomal membranes, whereas absence of amino acids causes the translocation of mTORC1 from this compartment into the cytosol. Two protein complexes are responsible for the localization of mTORC1 to late endosomal/lysosomal membranes: a heterotetrameric complex of the RAG GTPases and a multimeric complex termed RAGULATOR, both of which are present on the late endosomal/lysosomal compartment constitutively ([@bib27]; [@bib43], [@bib42]). Activation state of the RAGs is partially determined by the RAGULATOR acting as a nucleotide exchange factor ([@bib5]) and by an additional complex known as the GATOR acting as a GTPase activating protein ([@bib3]) although it is also possible to activate mTORC1 downstream of amino acids in a way that is independent of the RAGs but still sensitive to the vacuolar ATPase ([@bib24]). In addition to the fundamental role of amino acids acting via the RAG/RAGULATOR axis, a small GTPase termed RHEB is also essential for mTORC1 activation ([@bib14]). This appears to be achieved via the amino acid-dependent translocation of the GTPase activating protein for RHEB termed TSC2 to the lysosomal surface ([@bib13]).

A fundamental question of whether the primary amino acid sensor(s) are at the plasma membrane or inside the cell is not completely answered ([@bib12]; [@bib17]; [@bib22]). The majority of recent work concludes that the sensors are internal, suggesting that amino acid transport to the cell interior is critical. A model proposed by Murphy and colleagues describes a coupled pathway whereby L-glutamine is first imported, then rapidly exported with the simultaneous import of L-leucine and other essential amino acids leading to mTORC1 activation ([@bib36]). Other recent work suggests that cytosolic leucyl-tRNA synthetase is a leucine sensor and activates mTORC1 ([@bib20]; [@bib7]), consistent with the known primacy of leucine among amino acids in activation of mTORC1. An "inside-out" sensing mechanism has also been proposed whereby amino acids in the lysosomal lumen are sensed by the vacuolar ATPase, and this signal is transmitted to the lysosomal exterior for activation of the RAGULATOR ([@bib51]). All of these data support the idea that amino acids ultimately activate mTORC1 in the cell interior, and probably more than one type of sensing (and amino acid) is involved. For example, although leucine is sensed by the Sestrin1/2 proteins ([@bib48]), recent work demonstrates that levels of arginine entering the lysosomes via transporter SLC38A9 are also important for mTORC1 activation ([@bib39]; [@bib46]). At the same time, arginine is also sensed by the CASTOR1/2 proteins in the cytosol ([@bib11]) suggesting that even for the same amino acid multiple sensors in distinct cellular sites may be involved. On the other hand, it should also be mentioned that some older experiments showed that non permeable amino acid analogues can inhibit autophagy ([@bib34], [@bib35]), suggesting that sensing may also involve events at the plasma membrane.

The exact spatial and temporal dynamics of the activation of mTORC1 upon amino acid stimulation are not understood owing to the difficulty of generating tagged versions of the kinase amenable to live imaging that still maintains physiological localization characteristics. In addition, making stable cell lines with other mTORC1 components such as RAPTOR also results in dynamics that differ significantly from the endogenous complex (unpublished results). We have tried to overcome this problem in two different cell lines and using two different strategies. In HEK-293 cells, we have down-regulated endogenous RAPTOR while simultaneously expressing exogenous tagged constructs; in the near haploid HAP-1 cells we have tagged the endogenous RAPTOR gene with GFP. We describe here the dynamics of activation of the mTORC1 complex in these cells, with special emphasis in the HAP-1 cells. To examine whether mTORC1 responds directly to lysosomal amino acids, we have also generated a cell permeant fluorescent analogue of leucine in order to image RAPTOR translocation in response to this compound.

Results {#s2}
=======

Amino acid-dependent mTOR localization in fixed cells {#s2-1}
-----------------------------------------------------

We compared the timing of the translocation of the endogenous mTOR to a punctate compartment in response to amino acids with the phosphorylation of S6K, one of mTORC1's main substrates ([Figure 1A--C](#fig1){ref-type="fig"}). As previously reported ([@bib43]), in fed cells mTOR was partially in LAMP-1-positive punctate structures but became cytosolic during starvation from growth factors and amino acids (B). Upon re-stimulation with just amino acids, mTOR was found in a punctate distribution with a peak at 5 min (B, C). In a parallel experiment, mTOR phosphorylated S6K with a peak at 10 min of amino acid re-stimulation and phosphorylation continued to be strong even at 20 min (A). The discrepancy in the timing of mTOR translocation versus activity could be a natural delay until the complex becomes fully competent for phosphorylation. We noted however that in time points where the intensity of mTOR staining on lysosomes was back to low levels, phosphorylation of S6K was still strong (20 min), indicating that the pool of mTOR undertaking phosphorylation may not have been fully on the lysosomes. We also examined the localization of the direct mTORC1 target 4EBP1 as well as the S6K target the S6 protein under these conditions using antibodies that stain the endogenous phosphorylated proteins. The phosphorylated form of 4EBP1 did not localize on LAMP-1-positive lysosomes upon amino acid stimulation where activated mTOR would be expected to reside ([Figure 1](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1A--C](#fig1s1){ref-type="fig"}). Similarly, the phosphorylated form of S6 was also not localised to LAMP-1-positive lysosomes at any time during recovery ([Figure 1](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1D,E](#fig1s1){ref-type="fig"}).10.7554/eLife.19960.003Figure 1.Activation of mTOR components in response to amino acids.HEK-293 cells were starved of amino acids and growth factors, and re-stimulated for the indicated times with MEM amino acids. (**A**) The phosphorylation of S6K at T389 was established as a surrogate for mTORC1 activity. Band marked with an asterisk serves as loading control. (**B**) Under the same conditions the localization of mTOR and the LAMP-1 lysosomal protein were examined by indirect immunofluorescence using antibodies that recognise the endogenous protein. (**C**) The total intensity of mTOR- or LAMP-1-positive puncta for the conditions shown in (**B**) were quantitated and plotted. We used 2 biological replicates with 10 technical repeats (10 regions of interest) and the error bars represent standard error of the mean. (**D**) HEK-293 cells were co-transfected with siRNAs targeting the 3' (si-1) and the 5' (si-2) untranslated region of RAPTOR together with plasmids expressing RAPTOR-GFP for 3 days. Levels of endogenous RAPTOR and the exogenous tagged protein were determined with RAPTOR antibodies. (**E**) Live cell imaging of samples as in **D**. Cells were starved of amino acids and growth factors and re-stimulated either with starvation medium (starved) or with amino acids (aa add) for the indicated times. Representative frames are shown. The change to either starvation or amino acid medium was done after 90'' of incubation. The bar in all panels represents 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.003](10.7554/eLife.19960.003)10.7554/eLife.19960.004Figure 1---figure supplement 1.Localization of mTOR-phosphorylated 4EBP1 and S6K-phosphorylated S6 in response to amino acid stimulation.(**A--C**) HEK-1 cells were starved of amino acids and growth factors for 60' and re-stimulated with starvation medium containing MEM amino acids for the indicated times. Some samples were stained with antibodies to endogenous phosphorylated (T37/46) 4EBP1 and endogenous LAMP-1 (**A** and **B**) whereas parallel samples were analysed by immunoblotting to reveal phosphorylated (T37/46) 4EBP1 (**C**). Note that for clarity we have shown the co-staining of phosphorylated 4EBP1 and LAMP-1 in (B) only for the selected regions shown in (**A**). (**D**, **E**). Cells treated as above were stained with antibodies to phosphorylated S6 and LAMP-1 (shown in **D**) or immunoblotted for phosphorylated S6K1 or phosphorylated S6 as indicated. Asterisk indicates irrelevant band serving as loading control. Bar in all panels represents 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.004](10.7554/eLife.19960.004)10.7554/eLife.19960.005Figure 1---figure supplement 2.Localization of overexpressed and endogenous RHEB in relation to mTOR.(**A**) HEK-293 cells were transfected with plasmids encoding HA-RHEB for 24 hr and were then fixed and stained for immunofluorescence with antibodies to HA and endogenous mTOR. (**B**) HEK-293 cells were transfected with empty vector (hygro) or with plasmids expressing either RHEB or RAGA simultaneously (all three conditions) with HA-tagged S6K1. After 24 hr, cells were kept in full medium or starved for 60 min and all samples were lysed and immunoprecipitated with HA antibodies. After electrophoresis and blotting, the blots were stained with antibodies to S6K phospho T389 or the other relevant proteins as indicated (**C**) HEK-293 cells were kept in full medium (fed), or starved and re-stimulated with starvation medium containing MEM amino acids for 20'. The cells were fixed and stained for immunofluorescence with antibodies to endogenous mTOR and endogenous RHEB. (**D**) HEK-293 cells were left untreated (control) or treated with 5 µg/ml Brefeldin A for 60' (BFA). After fixation the cells were stained for immunofluorescence with antibodies to endogenous RHEB or endogenous Giantin. (**E**) HEK-293 or HeLa cells were kept in full medium or starved for 60'. They were then fixed and stained for antibodies to endogenous TSC2. Bar in all panels represents 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.005](10.7554/eLife.19960.005)10.7554/eLife.19960.006Figure 1---figure supplement 3.Localization and activity of RHEB upon Golgi disruption.HEK-293 cells were kept in normal medium or treated with 5 µg/ml BFA for 60'. (**A**) After fixation and permeabilization, the cells were stained with antibodies to endogenous RHEB and RAGC as indicated. (**B**) After treatment, the samples were lysed and immunoblotted for S6K phospho T389 in order to ascertain the effect of RHEB redistribution on mTORC1 activation. Bar represents 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.006](10.7554/eLife.19960.006)

An important protein in mTOR signalling is RHEB, a small GTPase absolutely required for mTOR activity ([@bib14]). Current models suggest that RHEB and the mTOR complex interact on the lysosomes for subsequent mTOR activation. In our hands, overexpressed RHEB capable of activating mTOR independently of the amino acid presence was primarily localised to the ER and Golgi and co-localized very weakly with endogenous mTOR ([Figure 1](#fig1){ref-type="fig"}; [Figure 1---figure supplement 2A,B](#fig1s2){ref-type="fig"}). In addition, endogenous RHEB co-localized very weakly with the lysosomal pool of mTOR under fed conditions or upon a round of starvation and re-stimulation where interaction with mTOR would be expected to be maximal ([Figure 1](#fig1){ref-type="fig"}; [Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}). In fact, a substantial amount of immunostained RHEB in these cells co-localized with the Golgi protein Giantin, and its localization was sensitive to Brefeldin A ([Figure 1](#fig1){ref-type="fig"}; [Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}), a drug that causes Golgi disappearance into the endoplasmic reticulum ([@bib32]). An important regulator of RHEB activity is the TSC complex which inactivates RHEB by accelerating GTP hydrolysis, and it has been reported that the TSC2 protein cycles on and off the lysosomal surface in response to amino acid levels: when amino acids are withdrawn TSC2 translocates to the lysosomal surface where it inactivates RHEB causing the subsequent mTOR inactivation ([@bib13]). Although we could verify this amino acid dependent translocation of TSC2 in HeLa cells, in our HEK-293 cells this appeared to be either less evident or even in the opposite way (more perinuclear in fed cells and less in starved, [Figure 1](#fig1){ref-type="fig"}; [Figure 1---figure supplement 2E](#fig1s2){ref-type="fig"}). Of note, mTORC1 activation dynamics in response to amino acids are very comparable in HEK-293 and HeLa cells (data not shown). These results suggested that the lysosome is a crucial locus for mTOR activation but the dynamics of this process and how mTORC1 activity is connected to lysosomal residence may be more complicated than current models.

Dynamics of RAPTOR-GFP in HEK-293 cells {#s2-2}
---------------------------------------

To examine the dynamics of mTOR in response to amino acids we tried to express subunits of mTORC1 tagged with GFP in order to follow localization in live cells. Tagging either mTOR or RAPTOR with GFP at either N' or C' terminus and generating either transient or stable cell lines of varying expression levels did not provide us with model systems that recapitulated the dynamics of endogenous mTOR (data not shown). One approach that was partially successful was to transfect cells with siRNAs targeting the 3' and 5' untranslated regions of endogenous RAPTOR while simultaneously expressing transiently in the same cells RAPTOR-GFP ([Figure 1D](#fig1){ref-type="fig"}). In these cells, endogenous RAPTOR expression was greatly reduced and exogenous expression (resistant to the siRNAs) could be titrated to be similar to the endogenous. In live imaging experiments using these cells after a round of starvation (removing amino acids and growth factors) and re-stimulation (adding back amino acids) we observed a rapid translocation of RAPTOR-GFP to small and fine punctate structures within 1 to 2 min of amino acid addition ([Figure 1E](#fig1){ref-type="fig"}, panels labelled "aa add"). In contrast, re-stimulation of these cells with starvation medium alone did not reveal a translocation of RAPTOR-GFP ([Figure 1E](#fig1){ref-type="fig"}, panel labelled "starved"). Although this was a reproducible effect, it was evident in a minority of the cells in the population, primarily in those expressing very low levels of exogenous RAPTOR-GFP. This cell variability made it very difficult to prove by biochemical methods that mTOR was being activated and we did not pursue this line of experimentation further.

Generation of HAP-1 cells expressing RAPTOR-GFP from the endogenous locus {#s2-3}
-------------------------------------------------------------------------

An alternative approach was to introduce to the endogenous RAPTOR a GFP tag. For this we used HAP-1 cells which are derived from the near haploid cell line KBM-7 via an unsuccessful attempt at reprogramming ([@bib9]; [@bib8]). Using a CRISPR/Cas9 approach we derived a clone that expressed RAPTOR-GFP from the endogenous locus and at equal levels to the parental cells ([Figure 2A](#fig2){ref-type="fig"}). The fluorescence signal in these cells was sufficiently bright to be discerned by wide field microscopy ([Figure 2B](#fig2){ref-type="fig"}) although not strong enough for long illumination in confocal microscopy (data not shown). The levels of endogenous mTOR in these cells were equal to the wild type cells ([Figure 2A,C](#fig2){ref-type="fig"}) and the RAPTOR-mTOR complex could be immunoprecipitated with antibodies to endogenous mTOR ([Figure 2C](#fig2){ref-type="fig"}) using the lysis conditions in 0.3% CHAPS previously described ([@bib26]). In order to ensure that these cells could be used for live imaging in response to amino acid stimulation we characterised their mTORC1 signalling properties using as surrogates for mTORC1 activity the phosphorylation of two direct downstream targets: S6K and ULK1. In fed conditions the RAPTOR-GFP cells exhibited a slightly lower phosphorylation of S6K than the HAP-1 parental cells ([Figure 2D](#fig2){ref-type="fig"}). Both cells showed an inhibition of S6K and ULK1 phosphorylation upon starvation (removing amino acid and growth factors) and a comparable re-stimulation with their full growth medium (Iscove's modified Dulbecco's medium-IMDM [Figure 2D](#fig2){ref-type="fig"}, imdm10' and imdm20'). Interestingly, upon re-stimulation with MEM amino acids the RAPTOR-GFP cells were significantly less responsive than the parental ones \[[Figure 2D](#fig2){ref-type="fig"}, aa(MEM)10' and aa(MEM)20'\]. This was further explored by combining MEM and non-essential (NE) amino acids during re-stimulation. Whereas this made only a small difference to the parental cells ([Figure 2E](#fig2){ref-type="fig"}, HAP-1 lanes) it did significantly increase the response in the RAPTOR-GFP cells for both S6K and ULK1 phosphorylation ([Figure 2E](#fig2){ref-type="fig"}, lanes labelled "HAP-1 RAPTOR-GFP"). Of note, NE amino acids on their own did not activate mTOR in either cell line. From this point on, an "aa" designation for the HAP-1 RAPTOR-GFP cells will indicate a mixture of MEM and NE amino acids. Although a combination of amino acids activated mTOR to reasonable levels in the RAPTOR-GFP cells, this was not as high as in parental cells, or in RAPTOR-GFP cells stimulated with full growth medium. To overcome this, we added during re-stimulation two growth promoting factors, Insulin and EGF, and examined mTOR activation. These two growth factors, and especially Insulin, had a further enhancing effect although on their own they did not activate mTOR ([Figure 2F](#fig2){ref-type="fig"}, blot labelled 1% dial serum). All of these starvation and re-stimulation experiments were done in medium containing salts and 1% dialysed serum. When we repeated them in medium containing 1% BSA instead of dialysed serum we saw that in the parental cells re-stimulation was still largely dependent on amino acids and weakly on added growth factors whereas re-stimulation in the RAPTOR-GFP cells followed the requirements as above (weak with amino acids, further enhanced with growth factors) but it was to much lower final levels compared to the fed condition ([Figure 2F](#fig2){ref-type="fig"}, blot labelled 1% BSA). We also examined the response of the two HAP-1 cells and the HEK-293 cells to serum starvation on its own or in combination with a subsequent amino acid starvation. The activity of mTORC1 in both HAP-1 cells was remarkably resistant to overnight serum withdrawal whereas in HEK-293 cells this treatment completely inhibited mTORC1-directed phosphorylation of S6K ([Figure 2G](#fig2){ref-type="fig"}, first two lanes in each cell line). Consequently, stimulation of the serum starved cells with growth factors only stimulated HEK-293 cells and not the two HAP-1 cells ([Figure 2G](#fig2){ref-type="fig"}, third lane). Importantly, a subsequent amino acid starvation regime in all three cell lines followed by amino acid re-addition showed the expected inhibition and re-stimulation of mTORC1 ([Figure 2G](#fig2){ref-type="fig"} lanes 4 and 5), whereas growth factors on their own under these conditions did not re-activate mTORC1 ([Figure 2G](#fig2){ref-type="fig"}, lane 6). We concluded from all of this characterization that the RAPTOR-GFP cells can be used for analysing the dynamics of amino acid stimulation of mTORC1, but that the presence of RAPTOR-GFP in place of the endogenous RAPTOR makes the cells overall more dependent on additional factors (other than amino acids and present in serum) in order to obtain a maximal response. However, it should emphasised that in the RAPTOR-GFP cells it is the MEM amino acids that are driving mTORC1 activation even in the presence of the additional factors whereas serum withdrawal on its own has a minimal effect on mTORC1.10.7554/eLife.19960.007Figure 2.Characterization of HAP-1 cells expressing RAPTOR-GFP in place of endogenous RAPTOR.(**A**) Immunoblots of parental HAP-1 cells or HAP-1 cells expressing RAPTOR-GFP, in triplicate. (**B**) Fluorescence microscopy of cells as in A; both photos were taken at the same setting of brightness and similarly edited in Photoshop. The bar represents 10 µm. (**C**) Cells as in A were lysed in 0.3% CHAPS lysis buffer and lysates subjected to immunoprecipitation using either mTOR antibodies or antibodies to PAK1 used as an IgG control. After immunoprecipitation and electrophoresis the samples were blotted with antibodies to RAPTOR or to mTOR. (**D**) Cells as in A were kept in normal medium (Iscove's modified Dulbecco's medium -IMDM plus 10% FBS) or starved of amino acids and growth factors for 60 min in medium containing salts and 1% dialysed FBS. The cells were then re-stimulated for 10' or 20' either with normal growth medium (imdm) or with a mixture of MEM amino acids added to the starvation medium (aa). After lysis and electrophoresis the samples were immunoblotted for the indicated proteins. (**E**) Cells kept fed or starved as above were re-stimulated for 20 min with starvation medium containing a mixture of MEM amino acids, a mixture of non-essential (NE) amino acids or a combination of both. Detection was for S6K phospho T389 or ULK1 phospho S757. (**F**) Cells as in A were starved of amino acids and growth factors in medium containing salts and either 1% dialysed FBS (top panel) or 1% BSA (bottom panel). Re-stimulation for 20' was in medium containing either dialysed FBS or BSA matching the starvation condition and also containing amino acids (mixture of MEM and NE), amino acids plus Insulin and EGF, Insulin and EGF only or amino acids plus Insulin. Detection was for the indicated proteins. (**G**) Parental HAP-1 cells, HAP-1 cells expressing RAPTOR-GFP or HEK-293 cells as indicated were starved of serum overnight. Next day, some samples were also starved of amino acids for 60' as indicated and then re-stimulated for 20' in medium containing growth factors (Insulin and EGF) and/or amino acids. Detection was for S6K or S6K phospho T389.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.007](10.7554/eLife.19960.007)

Dynamics of translocation in response to amino acids {#s2-4}
----------------------------------------------------

The HAP-1 cells are not ideal for immunofluorescence analysis because they have a large nucleus and a small cytosol. Nevertheless when we examined the RAPTOR dynamics in these cells in response to amino acid starvation and re-stimulation we saw that, whereas the protein was primarily cytosolic in starved cells, it translocated to punctate structures upon amino acid stimulation ([Figure 3](#fig3){ref-type="fig"}). Importantly, these RAPTOR-GFP puncta co-localised with endogenous mTOR ([Figure 3A,C](#fig3){ref-type="fig"}) or RAGC ([Figure 3B,D](#fig3){ref-type="fig"}), indicating that the RAPTOR-GFP protein was localizing with its endogenous interacting partners. As expected, whereas mTOR was cytosolic during starvation and became punctate upon stimulation, RAGC was continuously present on punctate structures as reported before for other cell types. These punctate structures to which RAPTOR-GFP and mTOR translocated were lysosomes as revealed by co-localization with the lysosomal protein LAMP-1 ([Figure 3C,D](#fig3){ref-type="fig"} and see below).10.7554/eLife.19960.008Figure 3.Translocation of RAPTOR-GFP to mTOR- and RAGC-positive compartments in response to amino acid stimulation.(**A**, **B**). HAP-1 cells expressing RAPTOR-GFP were kept under fed conditions or were starved of amino acids and growth factors and re-stimulated with a mixture of MEM and NE amino acids for 15'. The cells were fixed and stained with antibodies to endogenous mTOR (**A**) or RAGC (**B**). Detection was for GFP (RAPTOR) or using red secondary antibodies for mTOR and RAGC. (**C**, **D**). Cells starved and re-stimulated as above were fixed and simultaneously stained for mTOR and LAMP-1 (**C**) or RAGC and LAMP-1 (**D**). The bar in all panels represents 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.008](10.7554/eLife.19960.008)

We then set out to examine the RAPTOR-GFP dynamics in these cells by live imaging. After a round of amino acid starvation and re-stimulation, the protein very rapidly translocated to puncta that were also positive for the co-expressed mRFP-LAMP-2 lysosomal protein ([Figure 4A](#fig4){ref-type="fig"} and [Video 1](#media1){ref-type="other"}). This translocation of RAPTOR-GFP to the lysosomal compartment was evident within 2 min of amino acid addition, very reminiscent of the dynamics that we saw in HEK-293 cells ([Figure 1D](#fig1){ref-type="fig"}), and it was substantially reduced by about 10 min of stimulation. Throughout the peak of translocation, RAPTOR-GFP was significantly co-localized with overexpressed mRFP-LAMP2 ([Figure 4A](#fig4){ref-type="fig"}, plot) or with endogenous LAMP-1 ([Figure 4B](#fig4){ref-type="fig"}). The dynamics of co-localization as measured by estimating a Pearson's coefficient suggest that soon after aa stimulation co-localization is 3-fold higher than basal levels, which returns close to baseline at later times ([Figure 4A](#fig4){ref-type="fig"}, plot). Of note, the localization of mRFP-LAMP-2 or of LAMP-1 was unaffected throughout the stimulation, indicating that what we observed was translocation of RAPTOR to pre-existing lysosomes.10.7554/eLife.19960.009Figure 4.Translocation of RAPTOR-GFP to lysosomes and its dynamics in response to amino acid stimulation.(**A**) HAP-1 cells expressing RAPTOR-GFP were co-transfected with plasmids expressing mRFP-LAMP2 for 24 hr. The cells were then starved of amino acids and growth factors for 60' and assembled on an imaging chamber still in starvation medium. Live imaging was started in a starvation medium for 2' followed by replacement with medium containing a mixture of MEM and NE amino acids for an additional 40'. Images were captured every 10''. Shown here are frames from such a movie in the two channels (GFP and red) the merged images and the co-localizing areas for the indicated time points. The extent of co-localization between RAPTOR-GFP and mRFP-LAMP2 as determined by the Pearson's coefficient is plotted on the graph. Images were background-subtracted using the rolling ball method in FIJI ([@bib44]) with a diameter of 10 pixels. Co-localization analysis was performed using Imaris software (Bitplane/Oxford Instruments) with thresholds for co-localization set using the auto function to avoid user bias. See also [Video 1](#media1){ref-type="other"}. (**B**) HAP-1 cells expressing RAPTOR-GFP were starved of amino acids and growth factors, and re-stimulated for 20'. The cells were stained for GFP (RAPTOR) and endogenous LAMP-1, and the extent of co-localization was determined by the Pearson's co-efficient (PCC) shown. (**C**) HAP-1 cells expressing RAPTOR-GFP were starved of amino acids and growth factors for 60' and set up for live imaging as above. Re-stimulation after 5' of imaging was in the starvation medium (starved), in the starvation medium containing a mixture of MEM and NE amino acids (aa's), or in medium containing amino acids and 2 µM concanamycin A (aa's + conc) for an additional 40'. Images were captured every 10''. Selected frames are shown. Note that in the concanamycin A-treated samples we found it necessary to pre-treat the cells for the last 10' of starvation with the compound before adding it again during re-stimulation. The bar in all panels represents 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.009](10.7554/eLife.19960.009)Video 1.Double imaging of RAPTOR-GFP and mRFP-LAMP2 in HAP-1 cells.After 55' of starvation in the incubator, cells were imaged for additional 5' of starvation on stage followed by on-stage addition of amino acid containing starvation medium. Display is at 15 frames per second. The last panel shows the co-localizing fraction which was used to derive a Pearson's coefficient plot. See also [Figure 4A](#fig4){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.010](10.7554/eLife.19960.010)10.7554/eLife.19960.010

An important recent observation was that amino acid-dependent mTOR stimulation is sensitive to inhibitors to the vacuolar ATPase ([@bib51]). Indeed, when cells were starved and re-stimulated with amino acids in the presence of concanamycin A, a potent vacuolar ATPase inhibitor, the translocation of RAPTOR-GFP to puncta was largely inhibited ([Figure 4C](#fig4){ref-type="fig"}, [Video 2](#media2){ref-type="other"} and [Figure 5C,D](#fig5){ref-type="fig"}).Video 2.Single imaging of RAPTOR-GFP HAP-1 cells.After 55 min of starvation in the incubator, cells were imaged for additional 5' of starvation on stage followed by on-stage addition of (1) starvation medium (2) amino acid containing starvation medium or (3) amino acid containing starvation medium plus 2 µM concanamycin A as indicated. Of note concanamycin A was also added for the last 10' of starvation. See also [Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}. Display is at 15 frames per second.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.011](10.7554/eLife.19960.011)10.7554/eLife.19960.01110.7554/eLife.19960.012Figure 5.Dynamics of RAPTOR-GFP translocation to lysosomes in comparison to mTOR activity.HAP-1 cells expressing RAPTOR-GFP were set up for parallel experiments: live imaging to reveal RAPTOR dynamics (**B**, **D**, **E**, **F**) and immunoblotting to reveal S6K phospho T389 (**A**, **C**) and ULK1 phospho S757 (**A**). Immunoblotting was for the indicated times after re-stimulation with a mixture of MEM and NE amino acids. The linearity of the detection for S6K phospho T389 is shown for ascending amounts of lysate (last two blots in **A**). In the experiment shown in **A**, re-stimulation was in triplicate. In the blot shown in C, concanamycin A was added to a final concentration of 2 µM for the indicated samples. In order to obtain graphs of RAPTOR translocation to punctate structures (**B** and **D**) we examined many cells for each condition coming from 3 to 4 independent imaging experiments (13 cells for control and 137 cells for aa's in panel b; 59 cells for aa's, 77 cells for aa's + EGF + Ins and 60 cells for aa's + conc in panel d). The number of puncta upon stimulation was counted in each cell using the Spots Detection function of Imaris software (Bitplane/Andor), and the average of all cells in each condition together with the standard deviation is plotted here. The number of cells responding to the various treatments and expressed as a percentage is shown in panels **E** and **F**, together with the statistical significance of the differences as indicated. Significance was evaluated using one-way ANOVA with a Bonferoni post-hoc test. Error bars represent standard error of the mean. (**G**) HAP-1 cells expressing RAPTOR-GFP were kept in fed conditions, starved for 60' or starved for 60' and re-stimulated with amino acids and growth factors for 5', 10', 20' and 30'. The RAPTOR-GFP protein was immunoprecipitated from these cells and the immunoprecipitates were analysed for a variety of potential interacting proteins as shown. All experiments were conducted in 0.3% CHAPS lysis buffer with the exception of the one labelled RAGA\* which was conducted in 0.3% deoxy big CHAP.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.012](10.7554/eLife.19960.012)10.7554/eLife.19960.013Figure 5---source data 1.Raw data file (excel) for [Figure 5](#fig5){ref-type="fig"} plots B and D.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.013](10.7554/eLife.19960.013)10.7554/eLife.19960.014Figure 5---figure supplement 1.Dynamics of de-phosphorylation and a simple model.(**A--B**) The phosphatase(s) de-phosphorylating S6K do(es) not show differential activity during amino acid stimulation. HAP-1 cells expressing RAPTOR-GFP were kept fed or starved of amino acids and growth factors for 60'. They were then re-stimulated with amino acids and growth factors for either 20' or 50' to generate two populations of mTOR-phosphorylated S6K. At the end of re-stimulation one sample from each population was kept and the rest received 1 µM PP242 -- an mTOR inhibitor -- for the indicated times (note that panel B shows a tighter time course in comparison to panel A). At the end of this treatment the samples were lysed and immunoblotted for S6K phospho T389 in order to ascertain the speed by which S6K became de-phosphorylated upon mTOR inhibition. (**C**) A model for mTORC1 transiently translocating to the lysosomal surface and then phosphorylating some of its substrates in the cytosol. Our data are consistent with the idea that soon after amino acid replenishment the mTORC1 complex translocates to the lysosome but it then comes off the lysosomes at later time points while still active towards its substrates.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.014](10.7554/eLife.19960.014)

Translocation of RAPTOR-GFP to punctate structures such as shown in [Figure 4C](#fig4){ref-type="fig"} and [Video 2](#media2){ref-type="other"} was robust and reproducible enough to allow us to plot translocation as a function of time after amino acid addition ([Figure 5B,D](#fig5){ref-type="fig"}). It is apparent that the response is very fast (evident within 2 min of amino acid addition) and returns to basal levels also quickly. In parallel experiments and using exactly the same media and cells on the same day we also determined in triplicate the activation of mTORC1 by biochemical methods ([Figure 5A](#fig5){ref-type="fig"}). Here we saw that phosphorylation of S6K was barely evident after 10 min of amino acid stimulation and continued to increase even at 30 min post stimulation. We will address this difference in the dynamics of translocation and activation at a later section. As discussed above, we also determined that the dynamics of RAPTOR-GFP translocation were sensitive to inhibition of the vacuolar ATPase using concanamycin A, and it agreed with the effects of this compound on mTOR activity ([Figure 5C,D](#fig5){ref-type="fig"}). In addition to its strong effects on the dynamics of translocation, concanamycin A also reduced by approximately 40% the number of cells that showed any response at all ([Figure 5E,F](#fig5){ref-type="fig"}). Finally, we compared directly the dynamics of translocation of RAPTOR-GFP in the presence of amino acids alone or amino acids plus EGF and insulin, conditions that enhance the phosphorylation response as shown in [Figure 2F](#fig2){ref-type="fig"}. In these experiments we did not see a difference in the dynamics of the response ([Figure 5D](#fig5){ref-type="fig"} and [Video 3](#media3){ref-type="other"}) but we did observe that a higher proportion of the cells in our fields of view showed translocation when growth factors were added ([Figure 5F](#fig5){ref-type="fig"}). We concluded from this that growth factors do not change the dynamics of the response but rather expand the number of cells capable of showing a response. RHEB is the protein that appears to integrate growth factor signalling to mTOR ([@bib14]); we hypothesise that the presence of GFP at the C terminus of RAPTOR may make the complex more dependent on growth factor inputs during amino acid stimulation. However, we emphasise that mTORC1 activation in these cells still depends on amino acids.Video 3.Single imaging of RAPTOR-GFP HAP-1 cells: comparison of response with amino acids vs.amino acids and growth factors. After 55' of starvation in the incubator, cells were imaged for additional 5' of starvation on stage followed by on-stage addition of (1) amino acid containing starvation medium or (2) amino acid plus insulin plus EGF containing starvation medium. See also [Figure 5D and F](#fig5){ref-type="fig"}. Display is at 15 frames per second.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.015](10.7554/eLife.19960.015)10.7554/eLife.19960.015

Sustained mTORC1 activity in comparison to its translocation dynamics {#s2-5}
---------------------------------------------------------------------

The observed kinetic difference between RAPTOR-GFP translocation and phosphorylation of its substrates suggests either that mTOR activity persists long after the complex has come off the lysosomal surface or that de-phosphorylation of S6K continuously antagonises the phosphorylation step in a way that does not allow the phosphorylated protein to accumulate at the early time points. To address the second possibility directly we examined the rate of dephosphorylation of S6K after a round of stimulation for different time points. First cells were starved and then re-stimulated with amino acids and growth factors for either 20 min or 50 min, at which point a mTOR inhibitor was added to block any further phosphorylation. The cells were then allowed to incubate for different times before phosphorylation of S6K was measured by immunoblots. In those experiments we saw that phosphorylation of S6K was rapidly lost within 5 min of incubation with the mTOR inhibitor and the dynamics of this were identical for the early and late points after stimulation ([Figure 5](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1A,B](#fig5s1){ref-type="fig"}). To investigate further the state of mTORC1 interactors during a round of starvation and re-stimulation we used immunoprecipitation of RAPTOR from these cells using the GFP tag ([Figure 5G](#fig5){ref-type="fig"}). In the 0.3% CHAPS lysis buffer, a substantial amount of the mTOR/RAPTOR complex can be isolated from fed cells and the stoichiometry of this complex is not altered during starvation and recovery ([Figure 5G](#fig5){ref-type="fig"}). We did not observe binding under our conditions of RHEB, ULK1 and ATG13, the latter two being autophagy proteins downstream of mTORC1 signalling. In contrast, we saw differential binding of RAGA to the complex: the protein was present in fed conditions, greatly reduced in starved cells and then binding was again evident until 20 of re-stimulation only to drop again afterwards. This was seen very reproducibly and with two independent conditions of lysis ([Figure 5G](#fig5){ref-type="fig"}, panels labelled RAGA and RAGA\*) and it provides further evidence that when mTORC1 activity is still very strong (for example at 30 min of re-stimulation, see [Figure 5A,C](#fig5){ref-type="fig"}) the interaction of mTOR with its known regulators is diminished.

Translocation in response to a fluorescent amino acid analogue {#s2-6}
--------------------------------------------------------------

We also addressed directly the temporal aspect of RAPTOR-GFP translocation in response to amino acid stimulation. Among amino acids, leucine has a prominent role in mTORC1 activation, and it has also been reported that a leucine methyl ester that enters cells and accumulates in lysosomes can activate mTORC1 on its own ([@bib51]). Prompted by this, we tested a series of leucine analogues for mTORC1 activation ([Figure 6](#fig6){ref-type="fig"}; [Figure 6---figure supplement 1A,B](#fig6s1){ref-type="fig"}). In our hands, a di-leucine methyl ester was a potent activator of mTORC1, much stronger that the single leucine methyl ester which was in turn much stronger than leucine itself ([Figure 6](#fig6){ref-type="fig"}; [Figure 6---figure supplement 1C](#fig6s1){ref-type="fig"}). Interestingly, a methyl ester of L-L-G was also a very strong activator of mTORC1 ([Figure 6](#fig6){ref-type="fig"}; [Figure 6---figure supplement 1C](#fig6s1){ref-type="fig"}). On this basis we synthesised a compound consisting of a double leucine followed by the Mant fluorophore, one of the smallest fluorescent molecules ([Figure 1](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}, fluorescent analogue). On its own, this analogue could activate mTORC1 after a round of starvation and re-stimulation at levels comparable to a mixture of NEM amino acids, albeit slightly slower but with the same sensitivity to the vacuolar ATPase inhibitor concanamycin A ([Figure 6](#fig6){ref-type="fig"}; [Figure 6---figure supplement 1D](#fig6s1){ref-type="fig"}). In addition, this analogue entered cells instantaneously upon addition, and targeted primarily the lysosomes in a way not inhibited by concanamycin A ([Figure 6](#fig6){ref-type="fig"}; [Figure 6---figure supplement 1E](#fig6s1){ref-type="fig"}). The fluorescent analogue was then used in the HAP-1 cells expressing RAPTOR-GFP. Here we found that whereas in the parental cells both the di-leucine methyl ester as well as the fluorescent analogue were capable of activating mTORC1 in medium containing growth factors and NE amino acids ([Figure 6A](#fig6){ref-type="fig"}, last two lanes of HAP-1 cells), this was much reduced in the cells expressing RAPTOR-GFP, once again suggesting that the presence of the transgene makes the cells dependent on a more complex activation mixture. Based on recent observations that arginine may be an equally important amino acid to leucine for mTORC1 activation ([@bib39]; [@bib46]), we then stimulated the RAPTOR-GFP cells with a mixture of arginine and the fluorescent analogue ([Figure 6B](#fig6){ref-type="fig"}). This condition proved to be favourable for activating mTORC1 \[lanes labelled aa(NE)/GF/FA/R in [Figure 6B](#fig6){ref-type="fig"}\]. Of note this activation, although it required all of the other components (growth factors, NE amino acids and arginine), it was absolutely dependent on the presence of the fluorescent analogue. We then used live imaging to examine the dynamics of RAPTOR-GFP translocation in response to the fluorescent analogue. We documented a very reproducible sequence of events whereby the analogue first entered lysosomes and, very shortly, RAPTOR-GFP started to translocate there ([Figure 6C](#fig6){ref-type="fig"}, and [Video 4](#media4){ref-type="other"}). Interestingly, although we never saw RAPTOR translocation to lysosomes devoid of the analogue, not all labelled lysosomes became RAPTOR positive. In the majority of cases we saw that the strongest-staining organelle became RAPTOR-positive first (example in [Figure 6D](#fig6){ref-type="fig"}), but we also saw examples where several lysosomes containing analogue became RAPTOR-positive simultaneously. In addition, we frequently saw that RAPTOR translocated to large vacuolar-like organelles containing the fluorescent analogue (example in [Figure 6E](#fig6){ref-type="fig"}). Amino acid methyl esters are known to continuously accumulate within lysosomes wherein the methyl ester moiety is hydrolysed and amino acids are trapped ([@bib40]); this provides a condition of continuous amino acid supply to provide sustained mTOR activation. To examine if this would also affect translocation, we quantitated translocation dynamics of RAPTOR-GFP in response to the fluorescent analogue ([Figure 6F](#fig6){ref-type="fig"}). It was clear that translocation under these conditions was sustained (albeit starting more slowly than the response with amino acids) and the RAPTOR-GFP protein did not come off the lysosomes throughout our live imaging time interval (30 min). This result provides additional evidence that translocation of the complex to the lysosomal surface is in direct response to amino acid levels in the lysosomal lumen.10.7554/eLife.19960.016Figure 6.Dynamics of RAPTOR-GFP translocation to lysosomes containing a fluorescent amino acid analogue.(**A**) Cells -- parental HAP-1 or those expressing RAPTOR-GFP -- were kept in normal medium (Iscove's modified DMEM plus 10% FBS) or starved of amino acids and growth factors for 60' in medium containing salts and 1% dialysed FBS. The cells were then re-stimulated for 20' either with normal growth medium (Isc) or with a mixture of non-essential (NE) amino acids and growth factors (GF) added to the starvation medium and also containing in some samples 0.1 mM LLOMe or 0.4 mM fluorescent analogue (FA) as indicated. After lysis and electrophoresis the samples were immunoblotted for S6K phospho T389 and ULK1 phospho S757 as indicated. (**B**) HAP-1 cells expressing RAPTOR-GFP were starved and re-stimulated as indicated above, but with the addition in some cases of 0.4 mM arginine (R) as indicated. After lysis and electrophoresis the samples were immunoblotted for S6K phospho T389 and ULK1 phospho S757 as indicated. (**C**--**E**) HAP-1 cell expressing RAPTOR-GFP were transfected with plasmids encoding mRFP-LAMP2 for 24 hr and then moved to a microscope stage for live imaging experiments. After 5' in starvation medium, the cells were stimulated with medium containing NE amino acids, growth factors, arginine and the fluorescent analogue as described in (**B**) above. Images were captured every 10''. Selected frames are shown in the three channels and as an overlay for panel **C**. Bar represents 10 µm. Only the GFP and fluorescent analogue channels are shown for (**D**--**E**). (**F**) The number of puncta containing RAPTOR-GFP upon stimulation with amino acids and growth factors (aa's) or with the fluorescent leucine analogue (FA) were counted in each cell using the Spots Detection function of Imaris software (Bitplane/Andor), and the average of all cells in each condition is plotted here. The plot also contains the number of puncta containing the fluorescent analogue (FA puncta) during the stimulation. The response to the fluorescent analogue comes from a total of 125 cells measured from seven different coverslips, each with 3 different regions of interest. Although not shown here for clarity reasons, the standard deviation for each measurement is comparable to that shown in [Figure 5B and D](#fig5){ref-type="fig"}. The amino acid response shown here comes from 59 cells and only the early points are shown for clarity. Because of the smaller number of cells this part of the plot is more bumpy than the ones shown in [Figure 5](#fig5){ref-type="fig"} but the kinetics were remarkably similar.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.016](10.7554/eLife.19960.016)10.7554/eLife.19960.017Figure 6---source data 1.Raw data file (excel) for [Figure 6](#fig6){ref-type="fig"} plot F.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.017](10.7554/eLife.19960.017)10.7554/eLife.19960.018Figure 6---figure supplement 1.A leucine-based fluorescent analogue that can activate mTORC1.(**A**) Chemical structures of leucine and various analogues examined here. (**B**) Steps in the chemical synthesis of the fluorescent analogue. (**C**) HEK-293 cells were kept in normal medium (fed), starved of amino acids and growth factors (starved) or re-stimulated with starvation medium containing individual amino acids and analogues as indicated for 20'. After lysis and electrophoresis the samples were immunoblotted for S6K phospho T389. Asterisk indicates irrelevant band serving as loading control. (**D**) HEK-293 cells as above were starved and re-stimulated with a mixture of MEM amino acids (aa) or 0.4 mM fluorescent analogue in the presence or absence of concanamycin A for the indicated times. After lysis and electrophoresis the samples were immunoblotted for S6K phosphoT389. Asterisk indicates irrelevant band serving as loading control. (**E**) HEK-293 cells stably expressing mRFP-LAMP2 were moved to a microscope stage for live imaging experiments. After 2' in starvation medium, fluorescent analogue was added. In some samples, concanamycin A was added for 5' before the addition of the fluorescent anaIogue and then throughout the rest of the experiment. Images were captured every 10 s and selected frames are shown in the two channels and as an overlay. The bar represents 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.018](10.7554/eLife.19960.018)Video 4.Triple imaging of RAPTOR-GFP cells expressing mRFP-LAMP2 and incubated with fluorescent analogue.Starved cells were imaged for 5' as above and fluorescent analogue was then added on stage with continuous imaging. Different overlays are shown in addition to the single channels. See also [Figure 7C](#fig7){ref-type="fig"}. Display is at 5 frames per second.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.019](10.7554/eLife.19960.019)10.7554/eLife.19960.019

Activation of mTORC1 by the amino acid analogue depends on Sestrin2 and on intact lysosomes {#s2-7}
-------------------------------------------------------------------------------------------

To our knowledge, the leucine analogue is the first fluorescent reagent capable of activating mTORC1 and at the same time visible by microscopy. In order to understand its mechanism of action further we set up parallel experiments in HEK-293 cells (where the analogue can activate mTORC1 completely on its own) and in the edited HAP-1 cells expressing RAPTOR-GFP (where activation is uniquely dependent on the analogue but also requires additional components). Given the recent work that Sestrin2 is a cytosolic sensor of leucine for mTORC1 activation ([@bib48]) we determined if this protein is also involved in sensing the analogue. In both cell types, down-regulation of Sestrin2 increased mTORC1 activation by regular amino acids and by the fluorescent analogue ([Figure 7A and B](#fig7){ref-type="fig"}). In HAP-1 cells, reduction in Sestrin2 levels caused a 3- to 4-fold increase in mTORC1 activation at 10' and 20' of amino acid addition, with the process of activation reaching a plateau by 30 min ([Figure 7A](#fig7){ref-type="fig"}). For fluorescent analogue addition, the enhancement of mTORC1 activation was maintained at the longer time point (30') as well ([Figure 7B](#fig7){ref-type="fig"}), consistent with the idea that lysosomal translocation of RAPTOR in response to the analogue is more sustained than to amino acids (see [Figure 6F](#fig6){ref-type="fig"}). In HEK-293 cells, in addition to the significant enhancement of mTORC1 re-activation for the Sestrin2 siRNA samples, we also consistently saw that the starting levels of mTOC1 activity were significantly higher ([Figure 7B](#fig7){ref-type="fig"}, compare fed samples). In addition, HEK-293 cells down-regulated for Sestrin2 showed a significantly more enhanced response to the fluorescent analogue in comparison to the effects of regular amino acids ([Figure 7B](#fig7){ref-type="fig"}). All of these data are consistent with the idea that Sestrin2 is a negative regulator of GATOR2, which is itself a key negative regulator of GATOR1, and therefore reduction is Sestrin2 de-represses that signalling cascade resulting in enhanced mTORC1 activation ([@bib48]). The finding that Sestrin2 reduction affects not only the starting levels of mTORC1 activity but the levels of its amino-acid induced reactivation is consistent with recent reports ([@bib38]; [@bib41]) and may indicate a dynamic equilibrium between Sestrin2 and GATOR2. Why does a lysosomally-targeted amino acid analogue still maintain dependence on Sestrin2 levels, a cytosolic sensor? One possibility is that a pool of analogue remains in the cytosol and never enters lysosomes. To address this possibility we asked whether intact lysosomes were important for the fluorescent analogue action by using GPN (glycyl-L-phenylalanine 2-naphththylamide) during recovery. GPN enters and accumulates in lysosomes leading to their rupture and has been historically used to implicate integrity of the organelles in several signalling pathways ([@bib6]). In both HAP-1 RAPTOR-GFP and in HEK-293 cells, GPN significantly inhibited the ability of the fluorescent analogue to activate mTORC1 ([Figure 7C and E](#fig7){ref-type="fig"}) whereas its effects when amino acids were added were also evident (but less strong in the case of HAP-1 cells). Interestingly, whereas lysotracker staining of lysosomes was completely eliminated by GPN in both cell types ([Figure 7D and F](#fig7){ref-type="fig"}, top panels) the fluorescent analogue still accumulated ([Figure 7D and F](#fig7){ref-type="fig"}, bottom panels). Of note, activation of mTORC1 in response to the fluorescent analogue was also sensitive to vacuolar ATPase inhibitors for HEK-293 cells ([Figure 6](#fig6){ref-type="fig"}; [Figure 6---figure supplement 1D](#fig6s1){ref-type="fig"}) and for HAP-1 RAPTOR-GFP cells (not shown).10.7554/eLife.19960.020Figure 7.Activation of mTORC1 in HAP-1 RAPTOR-GFP cells and in HEK-293 cells depends on Sestrin2 and intact lysosomes.(**A**) HAP-1 cells expressing RAPTOR-GFP were treated with siRNA against Sestrin2 or with a non-targetting control (NT) as indicated. After 72 hr, cells were kept in normal medium (Iscove's modified Dulbecco's medium -IMDM plus 10% FBS) or starved of amino acids and growth factors for 60' in medium containing salts and 1% dialysed FBS. The starved cells were then re-stimulated for 10', 20' or 30' with a mixture of amino acids and growth factors (aa) or with fluorescent analogue (fa) added to the starvation medium as indicated. After lysis and electrophoresis the samples were immunoblotted for the indicated proteins. The intensity of the S6K phospho T389 band is plotted in the graphs. This experiment is representative of two. (**B**) The same experiment as in A was done with HEK-293 cells. This experiment is representative of two. (**C**) HAP-1 cells expressing RAPTOR-GFP were kept in normal medium or starved and re-stimulated for 20' and 30' with amino acids and growth factors (aa) or with fluorescent analogue (FA) in the presence or absence of GPN as indicated. After lysis and electrophoresis the samples were immunoblotted for the indicated proteins. (**D**) Cells as in C were loaded with lysotracker or with fluorescent analogue (FA) for 30' during aa re-stimulation in the presence or absence of GPN as indicated. After fixation the cells were examined by fluorescence microscopy. (**E**) HEK-293 cells were kept in normal medium or starved and re-stimulated for 20' with MEM amino acids (aa) or with fluorescent analogue (FA) in the presence or absence of GPN as indicated. After lysis and electrophoresis the samples were immunoblotted for the indicated proteins. (**F**) Cells as in **E** were loaded with lysotracker or with fluorescent analogue (FA) for 20' during aa re-stimulation in the presence or absence of GPN as indicated. After fixation the cells were examined by fluorescence microscopy. The bar in all panels represents 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.020](10.7554/eLife.19960.020)10.7554/eLife.19960.021Figure 7---figure supplement 1.Properties of the fluorescent leucine analogue in mTORC1 activation.(**A**) HEK-293 cells were starved of amino acids and growth factors, and re-stimulated for the indicated times with MEM amino acids in the presence or absence of concanamycin A (2 µM) or EIPA (100 µM) as indicated. After lysis and electrophoresis the samples were immunoblotted for the indicated proteins. The intensity of the S6K phospho T389 band is plotted in the graph. Data from 3 experiments. (**B**) Experiment as in **A**, but samples were stimulated with 0.4 mM di-leucine methyl ester in the absence of any other addition. (**C**) Samples as in **A** and **B** but stimulated with 0.4 mM fluorescent analogue on its own in the presence of absence of 100 µM EIPA as indicated. All graphs represent n = 3. Values represent mean ± SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.021](10.7554/eLife.19960.021)

We also examined whether activation of mTORC1 by amino acids versus the fluorescent analogue could be mechanistically distinguished on the basis of sensitivity to macropinocytosis inhibitors based on recent observations that macropinocytosis of extracellular amino acids regulates mTORC1 activation ([@bib37]; [@bib50]). First, we showed that activation of mTORC1 via amino acids was sensitive to the macropinocytosis inhibitor 5-(*N*-ethyl-*N*-isopropyl) amiloride (EIPA), especially at later times after stimulation ([Figure 7](#fig7){ref-type="fig"}; [Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"}) whereas the di-leucine methyl ester (LLOMe), which served as the basis for synthesising the amino acid analogue (see [Figure 6](#fig6){ref-type="fig"}, [Figure 1](#fig1){ref-type="fig"}), was insensitive to inhibition by EIPA ([Figure 7](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1B](#fig7s1){ref-type="fig"}). Under the same conditions, stimulation by amino acids or LLOMe was sensitive to the vacuolar ATPase inhibitor concanamycin A ([Figure 7](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1A and B](#fig7s1){ref-type="fig"}). The same differential sensitivity to EIPA was also seen for the fluorescent analogue itself such that stimulation of mTORC1 via the fluorescent analogue was insensitive to EIPA ([Figure 7](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1C](#fig7s1){ref-type="fig"}).

These data suggest that the fluorescent analogue requires intact and functional lysosomes to signal to mTORC1 and that its mechanism of being sensed depends on Sestrin2 although it does not require delivery via macropinocytosis.

Discussion {#s3}
==========

We examined the spatiotemporal dynamics of mTOR activation and its kinetic dependence on amino acid presence. Pioneering work from several laboratories had already provided strong evidence that mTOR itself translocates to lysosomes during amino acid re-stimulation ([@bib43], [@bib42]; [@bib51]), but this work had relied exclusively on a single antibody that can stain the endogenous protein and it did not provide any information on the dynamics of the process. The RAPTOR-GFP edited cells that we used here provide a unique tool to address this question in a near-physiological setting. Although they are slightly less responsive to stimuli than the parental cells and require a more carefully assembled mixture of activators, they nevertheless show absolute reliance on amino acids for mTORC1 activation and RAPTOR translocation to lysosomes. Our work shows that translocation is a very fast and relatively transient event that peaks early and then returns to base line, whereas phosphorylation of substrates under identical conditions and measured in parallel continues for some time thereafter. We have also demonstrated for the first time that the presence of an amino acid analogue in the lysosomal lumen is sufficient to induce the translocation of RAPTOR-GFP there. This analogue, a methyl ester of di-leucine with a fluorescent moiety attached, produces a sustained translocation of the complex presumably owing to its property to continuously accumulate within the lysosomal lumen. All of these data provide for the first time a dynamic view of mTORC1 activation in response to amino acids.

Despite tremendous progress, the exact mechanism by which mTORC1 senses amino acids appears very complex and incomplete at present (reviewed and commented on in: [@bib18]; [@bib31]; [@bib45]). Clearly, several different sensors are involved (sometimes for the same amino acid, e.g. for arginine), and the topology of the phenomenon involves the cytosol as well as the lysosomal membrane and the lysosomal lumen. Our own data in two cell types argue that, in addition to intact lysosomes and the lysosomal ATPase, the cytosolic sensor Sestrin2 is required as well, even when the activating moiety is a lysosomally targeted amino acid methyl ester derivative. One possible explanation may be that amino acids are first imported into the lysosomes and then exported in a regulated manner (requiring intact lysosomes and lysosomal function) in order to be sensed by Sestrin2 and other such cytosolic sensors. The import step may depend on macropinocytosis ([@bib37]; [@bib50]) but the timing of the RAPTOR translocation step places a restraint on possible trafficking steps (see below). Our data cannot exclude the possibility that glutaminolysis in synergy with leucine also activate mTORC1 in the HAP-1 cells ([@bib15]) but we consider it less likely to operate in HEK-293 cells where glutamine is absent from any stimulation medium.

The speed with which RAPTOR translocates to the lysosomes upon amino acid addition eliminates some potential routes of amino acid delivery to lysosomes, a question still unanswered. We consider it unlikely that import follows a canonical vesicular route, given the fact that fluid phase delivery to lysosomes takes longer than 10 min \[[@bib1] and our unpublished data\] whereas RAPTOR translocation is evident within 2 min. This is also the case for macropinocytotic delivery to lysosomes ([@bib50]). Alternatively, import into the cytosol via transporters (or via macropinosomes from where amino acids would be exported into the cytosol) would be fast enough, but then an equally fast second step would be needed for the import into the lysosomes. It will be important to understand the dynamics of this step, especially in view of the fast kinetics reported here. The data with the fluorescent analogue and with the di-leucine methyl ester argue that all of these steps can be bypassed completely as long as the activating moiety is delivered to functional lysosomes, in agreement with previous work ([@bib51]). For both the methyl ester and the fluorescent analogue we have looked but did not see any macropinocytosis activation (our unpublished data).

Our work also revealed an apparent uncoupling between the translocation of mTORC1 to the lysosomes and the kinetics of mTORC1 target phosphorylation. In both HAP-1 cells edited to express endogenous RAPTOR-GFP and in HEK-293 cells stained for endogenous mTOR, phosphorylation of S6K and ULK1, major and direct mTORC1 targets, persisted long after translocation to the lysosomes had peaked and had returned to levels approaching the base line. This result implies that activated mTORC1 may exist in the cytosol, and not exclusively on the lysosomal surface. In line with this, a direct target of mTORC1 in this pathway, the protein 4EBP-1, was never detected to accumulate on lysosomes ([Figure 1](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). We have also provided data showing that RHEB, an essential protein for mTORC1 activation, was not concentrated on lysosomes under any conditions in these cells, being partially localised to the ER/Golgi endomembrane system ([Figure 1](#fig1){ref-type="fig"}; [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Even when the Golgi localization of RHEB was disrupted with BFA (a treatment that had a very modest effect on mTORC1 activity), very little of the protein co-localized with RAGC, a major mTORC1 regulator residing on lysosomes ([Figure 1](#fig1){ref-type="fig"}; [Figure 1---figure supplement 3A and B](#fig1s3){ref-type="fig"}). All of this data in combination re-emphasise the importance of the lysosome as a key organelle involved in mTORC1 signalling but they provide some important modifications to the existing model. According to the current view lysosomes serve as platforms for the interaction between the mTORC1 complex (translocated there via its interaction with the RAGs and the Ragulator) and RHEB, leading to mTORC1 activation in situ. However, an alternative possibility is also worth considering in our view. It is possible that mTOR requires translocation to the lysosomal surface as part of the amino acid sensing function, but, subsequent to that, the complex comes off the membrane rapidly in order to phosphorylate its substrates. According to this model, the lysosomal surface may not be a terminal destination where activated mTOR resides but rather a platform that casts activated mTORC1 into the cytosol ([Figure 5](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). Having the activated complex free to move in the cytosol would be consistent with the fact that the known mTORC1 substrates, which number in the thousands, range from cytosolic to membrane-bound proteins, and to some with nuclear localization ([@bib21]). This idea would also be consistent with the fact that very little visible RHEB resides on the lysosomes under any condition, and that the TSC2 localization on and off lysosomes is cell-type dependent and not always able to explain the dynamics of mTORC1 inactivation on the basis of TSC2 lysosomal localization ([@bib13]; [@bib33]; [@bib16]).

This dynamic view of the mTORC1 activation cycle requires answering the following question: what happens to mTORC1 on the lysosomal surface that allows activation to persist at later times? Two core proteins directly involved in mTORC1 activation are the RAG GTPases and RHEB, with the RAGs mediating mTORC1-RHEB interaction, and RHEB having an irreplaceable role as a co-factor during activity. In our edited cells, we were able for the first time to immunoprecipitate quantitatively all of the endogenous RAPTOR protein and to examine its binding partners. We consistently saw in RAPTOR/mTOR immunoprecipitates dynamic binding of the RAGA protein to the complex: it was greatly diminished during starvation and then re-bound to the complex early after amino acid recovery only to diminish again at the last time point ([Figure 5G](#fig5){ref-type="fig"}). Of note, when - based on live imaging - the RAPTOR-GFP translocation to the lysosomes was back to low levels during amino acid recovery, the protein was still bound to RAGA based on the immunoprecipitation experiments. This would suggest the possibility that translocation to the lysosomal surface may allow mTORC1 to acquire activated RAG proteins before returning to the cytosol. This sustained interaction with the RAG proteins away from the lysosomal surface may generate a "primed" mTORC1 complex which can interact with RHEB in various locations and lead to activity.

Materials and methods {#s4}
=====================

All chemicals were obtained from Sigma-Aldrich with the exception of concanamycin A which was from Tocris.

Cell lines, antibodies, plasmids, siRNAs {#s4-1}
----------------------------------------

HEK-293 cells were obtained as part of an adenovirus expression system from Microbix (<https://microbix.com/what-we-do/adenovirus-vectors/adenovirus-price-list/>) and were tested for mycoplasma contamination every 2 years in our lab using Mycoguard (Genecopoeia, <http://www.genecopoeia.com/product/mycoplasma-detection-kit/>). HAP-1 cells and the RAPTOR-GFP edited cells were obtained from Haplogen (now part of Horizon Genomics <https://www.horizondiscovery.com/>) and were tested for mycoplasma contamination every 2 years. The following antibodies were used. Mouse anti-β-COP (a kind gift from the late Thomas Kreis), mouse anti-LAMP2 (Developmental Studies Hybridoma Bank, PRID: [AB_528129](https://scicrunch.org/resolver/AB_528129)), rabbit anti-phosphoS6K1 (Cell Signaling, PRID: [AB_330944](https://scicrunch.org/resolver/AB_330944)), rabbit anti-phosphoS6 (Cell Signaling, RRID: [AB_916156](https://scicrunch.org/resolver/AB_916156)), rabbit anti-mTOR (Cell Signaling, RRID:[AB_2105622](https://scicrunch.org/resolver/AB_2105622)), rabbit anti-RAGC (Cell Signaling, PRID:[AB_2180068](https://scicrunch.org/resolver/AB_2180068)), rabbit anti-RAPTOR (Cell Signaling, PRID:[AB_10694695](https://scicrunch.org/resolver/AB_10694695)), mouse ant-RHEB (Abnova, PRID:[AB_1112097](https://scicrunch.org/resolver/AB_1112097)), rabbit anti-phospho4EBP1 (Cell Signaling, PRID: [AB_560835](https://scicrunch.org/resolver/AB_560835)), rabbit anti-Giantin (Covance, PRID:[AB_291560](https://scicrunch.org/resolver/AB_291560)), rabbit anti-phosphoULK1 (Cell Signaling PRID: [AB_10829226](https://scicrunch.org/resolver/AB_10829226)), rabbit Sestrin2 (Proteintech Group, PRID:[AB_2185480](https://scicrunch.org/resolver/AB_2185480)). The following Plasmids were used. pRK5 HA GST Rheb1 from D Sabatini (Addgene 14951), RAGB from D Sabatini (Addgene 19301), myc-RAPTOR from D Sabatini (Addgene 1859). RAPTOR-EGFP was generated from myc-RAPTOR by excising the RAPTOR open reading frame, tailing it with restriction sites for Xho1 and EcoR1 and cloning it into the pEGFP-C1 vector. To target endogenous RAPTOR we used the following oligos:

si-1 targetting 3' untranslated region with sequence A.G.A.G.A.G.A.G.G.A.A.G.A.A.G.G.A.G.A.U.U

si-2 targeting 5' untranslated region with sequence G.G.G.C.U.G.A.U.G.A.G.A.U.G.A.G.U.U.U.U.U.

Generation of RAPTOR-GFP cell line {#s4-2}
----------------------------------

The RAPTOR-GFP cell line was created using a strategy based on that of Auer, et al ([@bib2]). HAP-1 cells were transfected with several plasmids: (1) a plasmid expressing Cas9, (2) a donor plasmid containing the GFP coding sequence flanked by zebra fish-specific guide RNAs and the zebra fish guide RNA sequence under the U6 promoter, (3) a plasmid expressing a guide RNA sequence (TGGAGAAGCGTGTCAGATAG) targeting the 3' end of the RAPTOR gene. When the donor plasmid is cleaved in the transfected cells, it will likely be integrated in the site targeted by the RAPTOR guide RNA. GFP positive transfected cells were sorted using FACS and subjected to single cell dilution to obtain clonal cell lines. These clonal cell lines were screened to search for cells which contained the GFP cassette integrated at 3' end of the RAPTOR gene. These cells are commercially available from Horizon Genomics.

Generation of fluorescent amino acid analogue {#s4-3}
---------------------------------------------

The synthetic route outlined in the scheme shown in Supplementary [Figure 4B](#fig4){ref-type="fig"} was followed using standard methods. All reagents are commercially available. The final product was freeze dried from water plus 5% acetic acid and re-suspended at 0.5 M in DMSO as a stock solution kept at --20°C.

Starvation of cells and re-stimulation with aa's {#s4-4}
------------------------------------------------

For starvation (both HEK-293 and HAP-1), cells were washed twice with pre-warmed starvation medium (140 mM NaCl, 1 mM CaCl~2~, 1 mM MgCl~2~, 5 mM Glucose, 20 mM Hepes, 5 mM KCl, pH 7.4) containing either 1% BSA or 1% dialysed FBS prior to incubation with this medium for 60 min. At the end of 60 min, the medium for HEK-293 cells was replaced with new starvation medium containing 2X solution of MEM amino acid solution (50X stock, containing the following amino acids in one letter code R, C, H, I, L, K, M, F, T, W, Y, V, and sold by LifeTechnologies), and incubated in this solution for the indicated times. For HAP-1 cells, the starvation medium was replaced with new starvation medium containing 1 mM glutamine, MEM amino acids as above, 2X solution of NE amino acids (100X stock, containing the following amino acids in one letter code G, A, N, D, E, P, S and sold by LifeTechnologies), insulin (1:500 dilution of liquid supplement at 9--11 mg/ml sold by Sigma-Aldrich) and EGF (20 ng/ml) as indicated in the Figure legends. In some experiments using the fluorescent analogue, we also added 0.4 mM arginine to the above solution.

Immunofluorescence and live imaging {#s4-5}
-----------------------------------

Cells for immunofluorescence were grown on glass coverslips and fixed in 3.7% formaldehyde in 200 mM Hepes pH 7.2. Staining for immunofluorescence and digital photography were done as described before ([@bib25]). Live-cell imaging was performed as previously described ([@bib25]) using a Nikon Ti-E-based system. Cells plated onto 60 plastic dishes were transferred onto 22-mm-diameter glass coverslips (BDH) and secured in an imaging chamber with 2 ml of cell medium or starvation medium added as indicated. The assembled imaging chamber was secured onto the microscope stage, and cells were maintained at 37°C using an OKO Labs full enclosure incubation system. The Nikon Ti-E-based system comprised a Nikon Ti-E microscope, 100x 1.4 N.A. objective (Nikon), SpecraX LED illuminator (Lumencor, Beaverton, OR), 410/504/582/669-Di01 and Di01-R442/514/561 dichroic mirrors (Semrock), Hamamatsu Flash 4.0 sCMOS camera, emission filter wheel (Sutter Instruments) and was controlled using Nikon Elements software. Compounds (fluorescent analogue, amino acids, and drugs) were added during imaging by flushing the solution in the imaging chamber with 5 ml of fresh solution containing the indicated additions.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for submitting your work entitled \"Dynamics of mTORC1 activation in response to amino acids\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Tony Hunter as the Senior Editor. Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

The reviewers found your work of interest but were very critical about the lack of controls and incorrect interpretation of the data. If you believe that you could improve the work, we would be happy to consider the work as a new submission. However, given the extensive requirements specified by the reviewers, we would understand if you choose to submit this work elsewhere.

1\) Being able to follow Raptor translocation with endogenous levels of protein could be valuable, but it appears that the Raptor-GFP fusion protein is a hypomorph, and does not fully recapitulate the function of native Raptor. For example, amino acids alone failed to activate mTORC1 in the Raptor-GFP HAP-1 cells unlike the parental HAP-1 cells, and maximal activation of mTORC1 in Raptor-GFP HAP-1 cells required both amino acids and growth factor stimulation, and even then it was not as strong as in parental HAP-1 cells. In this regard, both growth factors and amino acids are generally required for the full activation of mTORC1 in in mammalian cells, and therefore it is not clear why mTORC1 was fully activated in HAP-1 cells just by replenishing amino acids.

2\) The lag in S6K phosphorylation behind Raptor recruitment to lysosomes looks real, but the authors need to demonstrate that the anti-pT389 S6K blotting signal is linear before drawing a firm conclusion (it would be ideal if they could somehow monitor S6K phosphorylation in single cells in parallel with Raptor-GFP translocation).

3\) In contrast to the authors\' conclusion, the immunofluorescence images in [Figure 1B](#fig1){ref-type="fig"} show overlap between LAMP-1 and mTOR at all times. The authors should repeat the experiments with a Raptor antibody.

4\) Several figures: When assessing S6K, 4E-BP1 and S6 phosphorylation by immunoblotting, the authors should also blot for total levels of these proteins.

5\) [Figures 1A and D](#fig1){ref-type="fig"}, [2A](#fig2){ref-type="fig"}; [Figure 1---figure supplement 1C and E](#fig1s1){ref-type="fig"}; [Figure 1---figure supplement 3B](#fig1s3){ref-type="fig"}; Figure 5---figure supplement 5A-B; and [Figure 6---figure supplement 1C--D](#fig6s1){ref-type="fig"}. The authors should include a loading control.

6\) [Figure 2](#fig2){ref-type="fig"} -- the authors should determine if RAPTOR-GFP is localized to the lysosomes. In [Figure 3C, D](#fig3){ref-type="fig"} the authors showed some co-localization with LAMP-1. However, this was not quantified and most of the GFP-RAPTOR is not co-localized with LAMP-1. In addition there was not much change in GFP-RAPTOR localization in starved vs. fed conditions ([Figure 3A, B](#fig3){ref-type="fig"}).

To determine the functionality of RAPTOR-GFP, the authors exclusively rely on S6K phosphorylation measurements by immunoblot. It would be informative to measure other readouts such as 4E-BP1.

7\) [Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}. The authors should blot for total levels S6K (or HA), RHEB and RAGA in the lysate and immunoprecipitated samples. As is, they check only the phosphorylated form of S6K. Also, a negative control for the immunoprecipitation is missing.

8\) The authors did not provide mechanistic explanation for the observations presented in [Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}. Based on experiments using a fluorescent leucine methyl ester analogue, the authors seem to favor the \"inside out\" model of amino acid sensing in which amino acids are sensed in the lysosomal lumen. However, a recent study showed that cytoplasmic SESN2 is \"almost certainly\" the major leucine sensor upstream of mTORC1 (Wolfson RL et al. Science. 351:43). This recent study should be mentioned and discussed. How do the authors know that the mechanism of sensing the leucine analogue is the same as that of sensing a non-esterified leucine (based on the structure of the leucine-binding pocket in SESN2, it seems unlikely to accommodate this analogue)? The authors should determine if SESN2 depletion affects translocation of RAPTOR-GFP to lysosomes upon addition of the leucine analogue. If it does not, how do the authors reconcile their findings with those of Wolfson et al.?

Alternatively, if SESN2 depletion has an effect, how can the authors argue that accumulation in the lysosome lumen is physiologically relevant? The glutaminolysis model, which provides a sensing mechanism for leucine and glutamine in the mitochondria, should also be mentioned (Durán RV et al. Mol Cell. 2012. 47:349).

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for choosing to send your work entitled \"Dynamics of mTORC1 activation in response to amino acids\" for consideration at eLife. Your resubmission has been evaluated by Tony Hunter and the original Reviewing Editor who handled your submission. The editors are generally satisfied with the revisions made, but would like to ask you to address the following points.

On reading the resubmitted paper in depth, the conclusion drawn from the new data in [Figure 7](#fig7){ref-type="fig"} is somewhat puzzling. In these experiments the authors have addressed the requirement for Sestrin2 (Sesn2), a recently reported Leu sensor, for mTORC1 stimulation by their new fluorescent Leu analogue. Based on the work from the Sabatini lab and others, the prevailing current model is that Sesn2 binds to and inhibits the GATOR2 complex, which in turn inhibits GATOR1, a complex that acts as a RagA/RagC GAP to prevent Ragulator recruitment of mTORC1 to the lysosome. Leu binding to Sesn2 causes it to dissociate from GATOR2 allowing to inhibit GATOR1, which then leads to RagA/RagC activation and mTORC1 recruitment to the lysosome where it interacts with Rheb, i.e. GATOR2 is effectively an activator of mTORC1, and not \"a key negative regulator of mTORC1\", as the authors state in subsection "Activation of mTORC1 by the amino acid analogue depends on Sestrin2 and on intact lysosomes". Based on this model, the knockdown of Sesn2 and the consequent loss of its GATOR2 inhibitory activity would be expected to result in (partial) activation of mTORC1 in the absence of Leu (which is what the authors observed in HEK 293 cells). Moreover, if Sens2 were the only Leu sensor in the system, then one would expect mTORC1 activation to be insensitive to Leu in cells devoid of Sesn2.

1\) The new data in [Figure 7](#fig7){ref-type="fig"} show that partial depletion of Sesn2 increased mTORC1 stimulation by the FA Leu analogue and by amino acids, which on the face of it does not fit with the model described above. It is possible that Sesn2 is in excess over GATOR2, and that, even though Sesn2 levels have been reduced by si-Sestrin2, the remaining level of Sesn2 protein is sufficient to bind and inhibit all the GATOR2 complex, and that the lower level of Sesn2 somehow sensitizes the system to Leu (it would be better to use CRISPR technology to knock out Sesn2, but this would be beyond the scope of the paper). Other possible explanations are that Sesn1 is partially redundant with Sesn2 for Leu sensing in these cells or there is a second Leu sensor in the system that is affected by Sesn2 in some way. Ideally, what the authors should do is to re-express siRNA-resistant WT Sesn2 (this is a control for potential off target effects of si-Sestrin2 that is missing from [Figure 7](#fig7){ref-type="fig"}) and also Sesn2 L261A, which cannot bind Leu (did the authors try to model the FA Leu analogue into the Leu-binding pocket of Sesn2?) in the si-Sestrin2 treated cells, and check the response to FA Leu and amino acids.

2\) It would strengthen these data if GFP-Raptor translocation to lysosomes FA Leu and amino acid-induced were monitored in the Sesn2 knock HAP1-RAPTOR-GFP cells.

In sum, please provide a response to these issues and explain the apparent paradox that cells remain responsive to Leu after removal of a Leu sensor from the system.

10.7554/eLife.19960.024

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

*The reviewers found your work of interest but were very critical about the lack of controls and incorrect interpretation of the data. If you believe that you could improve the work, we would be happy to consider the work as a new submission. However, given the extensive requirements specified by the reviewers, we would understand if you choose to submit this work elsewhere.*

We thank the reviewers for the thorough evaluation of the manuscript and for suggesting important experiments to follow up. Below are our responses to specific comments.

One comment we want to make that may not have been clear in the original manuscript. The dynamic range of the fluorescence signal of the RAPTOR-GFP edited cells is much lower than a typical cell overexpressing a GFP-tagged protein, owing to the fact that expression in HAP-1 cells rely on the endogenous promoter. This limits to some extent the types of quantitations that we can do since small differences are unlikely to be reproducibly measured. The measurements that we reported are done with a lot of confidence but we cannot push the system further. To make this point clear I am attaching photos from the RAPTOR-GFP cells and HEK-293 cells expressing GFP-ATG13 together with the dynamic range of their intensity. Please note that the range for RAPTOR-GFP is 102-250 whereas for GFP-ATG13 is 5 times larger at 379-1088.10.7554/eLife.19960.022Author response image 1.**DOI:** [http://dx.doi.org/10.7554/eLife.19960.022](10.7554/eLife.19960.022)

*1) Being able to follow Raptor translocation with endogenous levels of protein could be valuable, but it appears that the Raptor-GFP fusion protein is a hypomorph, and does not fully recapitulate the function of native Raptor. For example, amino acids alone failed to activate mTORC1 in the Raptor-GFP HAP-1 cells unlike the parental HAP-1 cells, and maximal activation of mTORC1 in Raptor-GFP HAP-1 cells required both amino acids and growth factor stimulation, and even then it was not as strong as in parental HAP-1 cells. In this regard, both growth factors and amino acids are generally required for the full activation of mTORC1 in in mammalian cells, and therefore it is not clear why mTORC1 was fully activated in HAP-1 cells just by replenishing amino acids.*

There are two issues here.

A\) The edited cells being hypomorphs. This is correct and we have carefully documented it. However, we still were able to set up these cells to depend critically on amino acids for activation, and to re-capitulate the translocation of the mTORC1 component RAPTOR. Wherever possible, we have also supplemented the data with experiments from HEK-293 and parental HAP-1 cells. The original Sancak et al. paper describing for the first time mTOR translocation to lysosomes was published in 2008, but no live imaging for this phenomenon has been published since then to our knowledge. This is probably indicative of the problems in setting up this experiment. We think that the fact that the edited cells are hypomorphic must be evaluated against the fact that they are the first reagent to allow live imaging of this phenomenon.

B\) Interplay between amino acids and grown factors in mTORC1 activation. Here we have included a new experiment ([Figure 2G](#fig2){ref-type="fig"}) to show effects of serum and/or amino acid starvation in subsequent mTORC1 activation by amino acids and growth factors in HEK-293 or HAP-1 cells. This experiment shows serum starvation minimises mTORC1 activity which can then be stimulated with growth factors in HEK-293, whereas HAP-1 cells are resistant to this. However, both cells are sensitive to amino acid starvation and re-stimulation. Because in this work we are interested in the speed and dynamics of re-stimulation we chose from the beginning to use a 60 min total (amino acid and serum) starvation.

*2) The lag in S6K phosphorylation behind Raptor recruitment to lysosomes looks real, but the authors need to demonstrate that the anti-pT389 S6K blotting signal is linear before drawing a firm conclusion (it would be ideal if they could somehow monitor S6K phosphorylation in single cells in parallel with Raptor-GFP translocation).*

We have addressed this point by including a dose response blot for phospho-S6K in [Figure 5A](#fig5){ref-type="fig"} (bottom two blots) and by adding to most experiments in the paper blots for phospho-ULK1, another direct target of mTORC1. These additional data strengthened the original conclusion.

The last comment is of course the ideal experiment. It would require transfecting to the edited cells a FRET reporter for S6K activation and then looking at activity and translocation on a cell-by-cell basis. Several years ago a paper reported such a construct (Komatsu et al., (2011) MBC 22: 4647-56) and we obtained it at the time from the lab that published it with a view to use is as described above. We tried at the time to see if the reporter would show FRET after a round of amino acid starvation and re-stimulation, or after overnight serum starvation and re-stimulation with growth factors but it did not. We think that this reporter was oversold and that such a FRET reporter for S6K does not exist at present.

*3) In contrast to the authors\' conclusion, the immunofluorescence images in [Figure 1B](#fig1){ref-type="fig"} show overlap between LAMP-1 and mTOR at all times. The authors should repeat the experiments with a Raptor antibody.*

We clarify what the experiment in [Figure 1A](#fig1){ref-type="fig"} measures: we measured total intensity of staining per cell for LAMP-1 and mTOR for the same cells. Threshold was kept constant for *all* mTOR and *all* LAMP-1, but different between them to optimize the accuracy of the measurement. What we are claiming here is that whereas the intensity of LAMP-1 is constant, the intensity of mTOR peaks and then comes down. It is true that whatever pool of mTOR is still left in the intense staining region co-localizes with LAMP-1: what we are saying is that this amount/pool of mTOR is not constant but it peaks and comes down. For this submission we have repeated this experiment with somebody else's hands and we get the same result.

In order to provide an alternative quantitative description of the translocation of RAPTOR to lysosomes we derived a Pearson's coefficient from live cells expressing RAPTOR-GFP and LAMP2; this is shown in new [Figure 4A](#fig4){ref-type="fig"}.

In order to satisfy the request of examining this phenomenon with RAPTOR staining, we ordered and tried 5 different RAPTOR antibodies (Cell Signaling, Proteintech, Millipore). None works for iffl as shown by our siRNA experiments and we were unable to find in the literature reference to an antibody for RAPTOR validated for iffl.

*4) Several figures: When assessing S6K, 4E-BP1 and S6 phosphorylation by immunoblotting, the authors should also blot for total levels of these proteins.*

We have added the requested blots for the non-phosphorylated versions of these proteins.

*5) [Figures 1A and D](#fig1){ref-type="fig"}, [2A](#fig2){ref-type="fig"}, [Figure 1---figure supplement 1C and E](#fig1s1){ref-type="fig"}, [Figure 1---figure supplement 3B](#fig1s3){ref-type="fig"}, Figure 5---figure supplement 5A-B and [Figure 6---figure supplement 1C--D](#fig6s1){ref-type="fig"}. The authors should include a loading control.*

Wherever missing we have added a loading control. Please note that we tend to rely on the non-specific upper band revealed by the phospho-S6K antibody (marked with an asterisk in some blots), which, in our experience, is as good indicator of loading as any other band. We also load equivalent amount of protein in our blots after protein quantitation with the BCA reagent.

*6) [Figure 2](#fig2){ref-type="fig"} -- the authors should determine if RAPTOR-GFP is localized to the lysosomes. In [Figure 3C, D](#fig3){ref-type="fig"} the authors showed some co-localization with LAMP-1. However, this was not quantified and most of the GFP-RAPTOR is not co-localized with LAMP-1. In addition there was not much change in GFP-RAPTOR localization in starved vs. fed conditions ([Figure 3A, B](#fig3){ref-type="fig"}).*

To address this question we quantitated the extent of RAPTOR/LAMP2 co-localization using the Pearson's coefficient in live cells and in fixed cells. The plot for live cells is in [Figure 4A](#fig4){ref-type="fig"} and the values in fixed cells is in [Figure 4B](#fig4){ref-type="fig"}. In both cases, amino acid stimulation increases the co-localization between RAPTOR and LAMP2 by 2-3 fold. For the live cell experiment we included a Pearson's channel showing the co-localizing puncta in the revised [Video 1](#media1){ref-type="other"}. We also tried to quantitate the percentage of total RAPTOR that moves from the cytosol to the lysosomal locus during this stimulation, but are not yet comfortable with the data and therefore would rather not show them.

*To determine the functionality of RAPTOR-GFP, the authors exclusively rely on S6K phosphorylation measurements by immunoblot. It would be informative to measure other readouts such as 4E-BP1.*

For most blots, and certainly for all the critical ones, we have re-blotted for phospho-ULK1 (Ser 757), which is a very reliable reporter of mTORC1 activity directly linked to autophagy. These new data re-enforce our conclusions derived from phospho-S6K blots.

*7) [Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}. The authors should blot for total levels S6K (or HA), RHEB and RAGA in the lysate and immunoprecipitated samples. As is, they check only the phosphorylated form of S6K. Also, a negative control for the immunoprecipitation is missing.*

We have repeated this transfection and the new data are shown in [Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}. Our data are consistent with what we reported before, and please note that this strategy for activating mTOR has been used by us in other publications as well (Musiwaro et al., Autophagy 2013) so this is a well-controlled assay in the lab. In the process of re-doing this figure we realised that our control transfection was with RAGB and not RAGA. We apologise for this mistake in the previous version.

*8) The authors did not provide mechanistic explanation for the observations presented in [Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}. Based on experiments using a fluorescent leucine methyl ester analogue, the authors seem to favor the \"inside out\" model of amino acid sensing in which amino acids are sensed in the lysosomal lumen. However, a recent study showed that cytoplasmic SESN2 is \"almost certainly\" the major leucine sensor upstream of mTORC1 (Wolfson RL et al. Science. 351:43). This recent study should be mentioned and discussed. How do the authors know that the mechanism of sensing the leucine analogue is the same as that of sensing a non-esterified leucine (based on the structure of the leucine-binding pocket in SESN2, it seems unlikely to accommodate this analogue)? The authors should determine if SESN2 depletion affects translocation of RAPTOR-GFP to lysosomes upon addition of the leucine analogue. If it does not, how do the authors reconcile their findings with those of Wolfson et al.?*

*Alternatively, if SESN2 depletion has an effect, how can the authors argue that accumulation in the lysosome lumen is physiologically relevant? The glutaminolysis model, which provides a sensing mechanism for leucine and glutamine in the mitochondria, should also be mentioned (Durán RV et al. Mol Cell. 2012. 47:349).*

We have spent the majority of time trying to address this question and the results are shown in two new Figures ([Figure 7](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). First we determined whether down-regulation of Sestrin2 by siRNA would enhance activation via amino acids and/or the fluorescent analogue, and this data is in [Figure 7A](#fig7){ref-type="fig"} and B. For both HEK-293 and edited HAP-1 cells we found that Sestrin2 is a negative regulator of the response even when stimulation was with the fluorescent analogue-in fact the effects with the fluorescent analogue are stronger. We also determined that amino acids and the fluorescent analogue require intact lysosomes to activate mTORC1 in both HAP-1 and HEK-293 cells ([Figure 7C--F](#fig7){ref-type="fig"}). This is the case although there is fluorescent analogue associating with the lysosomes even when they are ruptured with GPN. Finally, we determined that whereas amino acid re-stimulation of mTORC1 is sensitive to the macropinocytosis inhibitor EIPA (this was done based on recent papers suggesting that macropinocytsis may underpin amino acid delivery), re-stimulation by di-leucine methyl ester or the fluorescent analogue is not ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). In our opinion all of this data argue that the methyl ester and the fluorescent analogue by-pass whatever macropinocytosis-related step is required for amino acid delivery and localise directly and quickly in the lysosomes. However, given the sensitivity of their activity to (a) vacuolar ATPase inhibitors and (b) intact lysosomes we believe that they then require exit from the lysosome in a form that can be sensed by sestrin2 in order to activate mTORC1.

\[Editors\' note: the author responses to the re-review follow.\]

*On reading the resubmitted paper in depth, the conclusion drawn from the new data in [Figure 7](#fig7){ref-type="fig"} is somewhat puzzling. In these experiments the authors have addressed the requirement for Sestrin2 (Sesn2), a recently reported Leu sensor, for mTORC1 stimulation by their new fluorescent Leu analogue. Based on the work from the Sabatini lab and others, the prevailing current model is that Sesn2 binds to and inhibits the GATOR2 complex, which in turn inhibits GATOR1, a complex that acts as a RagA/RagC GAP to prevent Ragulator recruitment of mTORC1 to the lysosome. Leu binding to Sesn2 causes it to dissociate from GATOR2 allowing to inhibit GATOR1, which then leads to RagA/RagC activation and mTORC1 recruitment to the lysosome where it interacts with Rheb, i.e. GATOR2 is effectively an activator of mTORC1, and not \"a key negative regulator of mTORC1\", as the authors state in subsection "Activation of mTORC1 by the amino acid analogue depends on Sestrin2 and on intact lysosomes". Based on this model, the knockdown of Sesn2 and the consequent loss of its GATOR2 inhibitory activity would be expected to result in (partial) activation of mTORC1 in the absence of Leu (which is what the authors observed in HEK 293 cells). Moreover, if Sens2 were the only Leu sensor in the system, then one would expect mTORC1 activation to be insensitive to Leu in cells devoid of Sesn2.*

We appreciate greatly the comments made by Tony Hunter and the original Reviewing Editor and the seriousness of their thinking. We have corrected the mistake of referring to GATOR2 "a key negative regulator of mTORC1" instead of a "key negative regulator of GATOR1" which is correct. The rest of the sentence and the concept described are correct.

*1) The new data in [Figure 7](#fig7){ref-type="fig"} show that partial depletion of Sesn2 increased mTORC1 stimulation by the FA Leu analogue and by amino acids, which on the face of it does not fit with the model described above. It is possible that Sesn2 is in excess over GATOR2, and that, even though Sesn2 levels have been reduced by si-Sestrin2, the remaining level of Sesn2 protein is sufficient to bind and inhibit all the GATOR2 complex, and that the lower level of Sesn2 somehow sensitizes the system to Leu (it would be better to use CRISPR technology to knock out Sesn2, but this would be beyond the scope of the paper). Other possible explanations are that Sesn1 is partially redundant with Sesn2 for Leu sensing in these cells or there is a second Leu sensor in the system that is affected by Sesn2 in some way. Ideally, what the authors should do is to re-express siRNA-resistant WT Sesn2 (this is a control for potential off target effects of si-Sestrin2 that is missing from [Figure 7](#fig7){ref-type="fig"}) and also Sesn2 L261A, which cannot bind Leu (did the authors try to model the FA Leu analogue into the Leu-binding pocket of Sesn2?) in the si-Sestrin2 treated cells, and check the response to FA Leu and amino acids.*

With respect to question and comment 1, we think that the most likely explanation may be that Sestrin2 is in excess over GATOR2 and down-regulating it has an enhancing effect upon stimulation. Similar observations have been reported in two recent papers of which the relevant sections are noted below and which we have now added in the reference and discussed briefly in the text in subsection "Activation of mTORC1 by the amino acid analogue depends on Sestrin2 and on intact lysosomes". \[Our aim with the Sestrin2 data is not to resolve the debate as to its exact role but to provide evidence that both the edited cells and the fluorescent analogue work within the canonical pathway.\]

\(a\) "Sestrin2 silencing in RKO cells enhanced the mTORC1 signaling in both starved and serumstimulated cells ([Figure 7F](#fig7){ref-type="fig"}), indicating that endogenous Sestrin2 indeed functions to inhibit mTORC1 signaling in human colon cancer cells." <http://dx.doi.org/10.7554/eLife.12204.001>

\(b\) "The sensitivity of mTORC1 signaling to amino acids was dependent on Sestrin gene dosage: the fewer alleles of Sestrins, the less dependence of MEFs on amino acids" Note in [Figure 7D](#fig7){ref-type="fig"} that in triple Sestrin KO cells amino acids enhance mTORC1 activity above the basal levels induced by FBS alone. <http://dx.doi.org/10.1016/j.cell.2014.08.038>

*2) It would strengthen these data if GFP-Raptor translocation to lysosomes FA Leu and amino acid-induced were monitored in the Sesn2 knock HAP1-RAPTOR-GFP cells.*

*In sum, please provide a response to these issues and explain the apparent paradox that cells remain responsive to Leu after removal of a Leu sensor from the system.*

With respect to question and comment 2, we had tried to see if in the Sestrin2 down-regulated cells we can observe a change in the dynamics of the RAPTOR translocation by live imaging. This was essentially what we tried to do before by modulating the levels of growth factors in the continuous presence of amino acids ([Figure 5D and F](#fig5){ref-type="fig"}) since we had seen effects in phospho-S6K phosphorylation. Unfortunately our resolution of the response by live imaging is not high enough to see such differences (this was also the case when we looked at growth factors before), so we prefer to show only the blots (which we have done in two different cell lines).

[^1]: These authors contributed equally to this work.
